Journal of Genomes and Proteomes

Editor in Chief

Dr. Yong-Bao Pan has completed his Ph. D in Genetics and Biochemistry from Iowa State University in 1990. He received 9 formal honors and awards like Outstanding Research Paper Award from USDA, Best Presentation Award from American Society of Sugar Cane Technologists, and Research Excellence Award from Iowa State University.etc. Currently he is working as a Research Plant Molecular Geneticist at…

Name : Yong-Bao Pan
University : United States Department of Agriculture, Agricultural Research Service (ARS)

Indexing and Listing

          

Recent Articles

  • article image

    Omic Technologies and Lung Cancer

    Lung cancer is the most common cause of cancer death in the world. According to results it’s nearly one in five (1.59 million deaths, 19.4% of the total). Studies show that smoking is the principal cause of the lung cancer. Among the multiple components of tobacco smoke such as polycyclic aromatic hydrocarbons, inorganic compounds, the tobacco specific…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial